ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
817 |
231K |
27 |
15:03 |
15:03 |
ASX - By Stock
|
817
|
231K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
817 |
231K |
55 |
08:14 |
08:14 |
ASX - By Stock
|
817
|
231K
|
55
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
817 |
231K |
38 |
08:05 |
08:05 |
ASX - By Stock
|
817
|
231K
|
38
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
21K |
7.5M |
11 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
21K
|
7.5M
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
21K |
7.5M |
29 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
21K
|
7.5M
|
29
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
21K |
7.5M |
25 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
21K
|
7.5M
|
25
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
21K |
7.5M |
15 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
21K
|
7.5M
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
36 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
40K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
34 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
40K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
58 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
40K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
47 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
40K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
RaceOncology
|
38 |
7.5K |
37 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
7.5K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
RaceOncology
|
38 |
7.5K |
25 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
7.5K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
RaceOncology
|
168 |
45K |
20 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
168
|
45K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
52 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
40K
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
20 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
40K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
73 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
40K
|
73
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
63 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
40K
|
63
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
51 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
40K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
20 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
40K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
95 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
146
|
40K
|
95
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
817 |
231K |
26 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
817
|
231K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
817 |
231K |
62 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
817
|
231K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
40K |
54 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
146
|
40K
|
54
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
RaceOncology
|
130 |
35K |
33 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
130
|
35K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
93 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
77K
|
93
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
RaceOncology
|
130 |
35K |
51 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
130
|
35K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
108 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
77K
|
108
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
29 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
77K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
63 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
77K
|
63
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
85 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
77K
|
85
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
44 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
77K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
33 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
77K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
32 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
77K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
37 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
77K
|
37
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
3.9M |
42 |
08/07/24 |
08/07/24 |
General
|
11K
|
3.9M
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
34 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
77K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
RaceOncology
|
168 |
45K |
11 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
168
|
45K
|
11
|
|
ASX - By Stock
|
RAC |
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
77K |
108 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
77K
|
108
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
757K |
47 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
2.2K
|
757K
|
47
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
3.9M |
28 |
03/07/24 |
03/07/24 |
General
|
11K
|
3.9M
|
28
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
757K |
18 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
2.2K
|
757K
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
3.9M |
34 |
03/07/24 |
03/07/24 |
General
|
11K
|
3.9M
|
34
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
3.9M |
57 |
03/07/24 |
03/07/24 |
General
|
11K
|
3.9M
|
57
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
RaceOncology
|
168 |
45K |
118 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
45K
|
118
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
RaceOncology
|
130 |
35K |
37 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
130
|
35K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
RaceOncology
|
80 |
24K |
62 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
24K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
RaceOncology
|
80 |
24K |
53 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
24K
|
53
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
RaceOncology
|
80 |
24K |
100 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
24K
|
100
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
RaceOncology
|
80 |
24K |
75 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
24K
|
75
|
|